biosimilar monoclonal antibody market

Global Biosimilar Monoclonal Antibody Market Analysis 2016-2020 and Forecast 2021-2026

  • Published Date: 2021-03-29
  • Report ID: 86631
  • Pages: 83
  • Format: prudent report format

Prudent Markets Snapshot

The global Biosimilar Monoclonal Antibody market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Biosimilar Monoclonal Antibody by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Synthetic Chemicals
Biopharmaceuticals
Others

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Biocon
Accord Healthcare
AET Biotech
Amgen
Celltrion
Reddy's Laboratories
Hospira
3SBio
Allergan
Alvartis

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Chronic & Autoimmune Diseases
Oncology
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)


Table of Contents
Table of Contents
1 Industry Overview
1.1 Biosimilar Monoclonal Antibody Industry
Figure Biosimilar Monoclonal Antibody Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Biosimilar Monoclonal Antibody
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Biosimilar Monoclonal Antibody
1.2.2 Downstream
Table Application Segment of Biosimilar Monoclonal Antibody
Table Global Biosimilar Monoclonal Antibody Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Biosimilar Monoclonal Antibody Market by Type
3.1 By Type
3.1.1 Synthetic Chemicals
Table Major Company List of Synthetic Chemicals
3.1.2 Biopharmaceuticals
Table Major Company List of Biopharmaceuticals
3.1.3 Others
Table Major Company List of Others
3.2 Market Size
Table Global Biosimilar Monoclonal Antibody Market 2016-2020, by Type, in USD Million
Figure Global Biosimilar Monoclonal Antibody Market Growth 2016-2020, by Type, in USD Million
3.3 Market Forecast
Table Global Biosimilar Monoclonal Antibody Market Forecast 2021-2026, by Type, in USD Million
4 Major Companies List
4.1 Biocon (Company Profile, Sales Data etc.)
4.1.1 Biocon Profile
Table Biocon Overview List
4.1.2 Biocon Products & Services
4.1.3 Biocon Business Operation Conditions
Table Business Operation of Biocon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Accord Healthcare (Company Profile, Sales Data etc.)
4.2.1 Accord Healthcare Profile
Table Accord Healthcare Overview List
4.2.2 Accord Healthcare Products & Services
4.2.3 Accord Healthcare Business Operation Conditions
Table Business Operation of Accord Healthcare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 AET Biotech (Company Profile, Sales Data etc.)
4.3.1 AET Biotech Profile
Table AET Biotech Overview List
4.3.2 AET Biotech Products & Services
4.3.3 AET Biotech Business Operation Conditions
Table Business Operation of AET Biotech (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Amgen (Company Profile, Sales Data etc.)
4.4.1 Amgen Profile
Table Amgen Overview List
4.4.2 Amgen Products & Services
4.4.3 Amgen Business Operation Conditions
Table Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Celltrion (Company Profile, Sales Data etc.)
4.5.1 Celltrion Profile
Table Celltrion Overview List
4.5.2 Celltrion Products & Services
4.5.3 Celltrion Business Operation Conditions
Table Business Operation of Celltrion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Reddy's Laboratories (Company Profile, Sales Data etc.)
4.6.1 Reddy's Laboratories Profile
Table Reddy's Laboratories Overview List
4.6.2 Reddy's Laboratories Products & Services
4.6.3 Reddy's Laboratories Business Operation Conditions
Table Business Operation of Reddy's Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Hospira (Company Profile, Sales Data etc.)
4.7.1 Hospira Profile
Table Hospira Overview List
4.7.2 Hospira Products & Services
4.7.3 Hospira Business Operation Conditions
Table Business Operation of Hospira (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 3SBio (Company Profile, Sales Data etc.)
4.8.1 3SBio Profile
Table 3SBio Overview List
4.8.2 3SBio Products & Services
4.8.3 3SBio Business Operation Conditions
Table Business Operation of 3SBio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Allergan (Company Profile, Sales Data etc.)
4.9.1 Allergan Profile
Table Allergan Overview List
4.9.2 Allergan Products & Services
4.9.3 Allergan Business Operation Conditions
Table Business Operation of Allergan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Alvartis (Company Profile, Sales Data etc.)
4.10.1 Alvartis Profile
Table Alvartis Overview List
4.10.2 Alvartis Products & Services
4.10.3 Alvartis Business Operation Conditions
Table Business Operation of Alvartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Biosimilar Monoclonal Antibody Sales Revenue 2016-2020, by Company, in USD Million
Table Global Biosimilar Monoclonal Antibody Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Biosimilar Monoclonal Antibody Sales Revenue Share in 2020, by Company, in USD Million
5.2 Regional Market by Company
Figure North America Biosimilar Monoclonal Antibody Market Concentration, in 2020
Figure Europe Biosimilar Monoclonal Antibody Market Market Concentration, in 2020
Figure Asia-Pacific Biosimilar Monoclonal Antibody MMarket Concentration, in 2020
Figure South America Biosimilar Monoclonal Antibody Market Concentration, in 2020
Figure Middle East & Africa Biosimilar Monoclonal Antibody Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Chronic & Autoimmune Diseases
Figure Biosimilar Monoclonal Antibody Demand in Chronic & Autoimmune Diseases, 2016-2020, in USD Million
6.1.2 Demand in Oncology
Figure Biosimilar Monoclonal Antibody Demand in Oncology, 2016-2020, in USD Million
6.1.3 Demand in Others
Figure Biosimilar Monoclonal Antibody Demand in Others, 2016-2020, in USD Million
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Biosimilar Monoclonal Antibody Demand Forecast 2021-2026, by Application, in USD Million
Figure Biosimilar Monoclonal Antibody Market Growth 2021-2026, by Application, in USD Million
Figure Biosimilar Monoclonal Antibody Market Share in 2026, by Application, in USD Million
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Biosimilar Monoclonal Antibody Production 2016-2020, by Region, in USD Million
7.2 Regional Market
Table Global Biosimilar Monoclonal Antibody Market 2016-2020, by Region, in USD Million
Table Global Biosimilar Monoclonal Antibody Market Share 2016-2020, by Region, in USD Million
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Biosimilar Monoclonal Antibody Market Size and Growth 2016-2020, in USD Million
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Biosimilar Monoclonal Antibody Market Size 2016-2020, by Country, in USD Million
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Biosimilar Monoclonal Antibody Market Size and Growth 2016-2020, in USD Million
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Biosimilar Monoclonal Antibody Market Size 2016-2020, by Country, in USD Million
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Biosimilar Monoclonal Antibody Market Size and Growth 2016-2020, in USD Million
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Biosimilar Monoclonal Antibody Market Size 2016-2020, by Country, in USD Million
7.3.4 South America
7.3.4.1 Overview
Figure South America Biosimilar Monoclonal Antibody Market Size and Growth 2016-2020, in USD Million
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Biosimilar Monoclonal Antibody Market Size 2016-2020, by Country, in USD Million
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Biosimilar Monoclonal Antibody Market Size and Growth 2016-2020, in USD Million
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Biosimilar Monoclonal Antibody Market Size 2016-2020, by Country, in USD Million
7.4 Regional Import & Export
7.5 Regional Forecast
Table Biosimilar Monoclonal Antibody Market Forecast 2021-2026, by Region, in USD Million
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.